Suppr超能文献

细胞因子基因多态性对 HLA 匹配同胞造血干细胞移植结局的影响。

The impact of cytokine gene polymorphisms on the outcome of HLA matched sibling hematopoietic stem cell transplantation.

机构信息

Clinical Pathology Department, National Cancer Institute, Cairo University, Cairo, Egypt.

Clinical Pathology Department, National Cancer Institute, Cairo University, Cairo, Egypt.

出版信息

Cytokine. 2018 Oct;110:404-411. doi: 10.1016/j.cyto.2018.05.003. Epub 2018 May 24.

Abstract

Graft-versus-host disease (GVHD) is the major complication of allogeneic hematopoietic stem cell transplantation (HSCT); cytokines are recognized as important mediators in its pathogenesis. In this study we investigated the role of cytokine gene polymorphisms on HSCT outcome. A total of 106 patient and 98 donors were genotyped by polymerase chain reaction sequence specific primers (PCR-SSP) based assay for tumor necrosis factor-α-308 (TNFα -308), interleukin (IL)-6-174, IL-10-1082, -819, -592, Interferon-γ+874 (IFN-γ+874), and transforming growth factor-β1 (TGF-β1) codon10 and 25 polymorphisms. Except one in each category, all patients and donors were TNFα -308 high producers and the majority were IL-6-174 high producers (93.3% and 90.8% respectively); a pattern that would alleviate any potential biological impact. Patient's IFN-γ+874 showed significant association with the development of chronic GVHD. Patients with IFN-γ +874 high producer showed an 8 folds likelihood to develop chronic GVHD as compared to those with IFN-γ+874 low producer predicted phenotype (95% CI: 1.59-40.2, p = 0.01). Patient's TGFβ1-codon 10 and 25 high/intermediate producers showed a lower incidence of acute GVHD though it did not achieve statistical significance (p = 0.065) on account of the low frequency of this genotype in our patients and donors (11.4 and 8.2% respectively). Other factors contributing to risk of GVHD included older age for both acute and chronic (p = 0.01 and 0.02 respectively) with age 24 as the best discriminating cutoff; CD34+ cell dose for chronic GVHD (p = 0.045) with a dose of 8 × 10/kg as the best discriminating cutoff; and conditioning regimen with Flu/Bu associated with the lowest incidence of acute GVHD (p = 0.003) and no impact on chronic GVHD. In conclusion the current study further indicates a potential role of some cytokine gene polymorphisms in the development of GVHD. The relative distribution of high and low producer genotypes in different ethnic groups contributes to their biological impact in different populations.

摘要

移植物抗宿主病(GVHD)是异基因造血干细胞移植(HSCT)的主要并发症;细胞因子被认为是其发病机制中的重要介质。在这项研究中,我们研究了细胞因子基因多态性对 HSCT 结果的影响。共对 106 名患者和 98 名供者进行了肿瘤坏死因子-α-308(TNFα-308)、白细胞介素(IL)-6-174、IL-10-1082、-819、-592、干扰素-γ+874(IFN-γ+874)和转化生长因子-β1(TGF-β1)密码子 10 和 25 多态性的聚合酶链反应序列特异性引物(PCR-SSP)检测。除了每一类中的一个,所有患者和供者都是 TNFα-308 的高产生者,大多数是 IL-6-174 的高产生者(分别为 93.3%和 90.8%);这种模式可以减轻任何潜在的生物学影响。患者的 IFN-γ+874 与慢性 GVHD 的发生有显著相关性。与 IFN-γ+874 低产生预测表型的患者相比,IFN-γ+874 高产生者发生慢性 GVHD 的可能性增加 8 倍(95%CI:1.59-40.2,p=0.01)。患者 TGFβ1-密码子 10 和 25 高/中间产物的急性 GVHD 发生率较低,但由于患者和供者的这种基因型频率较低(分别为 11.4%和 8.2%),因此没有达到统计学意义(p=0.065)。其他导致 GVHD 风险的因素包括急性和慢性 GVHD 的年龄较大(分别为 p=0.01 和 0.02),年龄 24 为最佳区分截点;慢性 GVHD 的 CD34+细胞剂量(p=0.045),最佳区分截点为 8×10/kg;Flu/Bu 联合调理方案与急性 GVHD 的发生率最低(p=0.003),但对慢性 GVHD 无影响。总之,本研究进一步表明,一些细胞因子基因多态性在 GVHD 的发生中可能具有潜在作用。不同种族群体中高产生者和低产生者基因型的相对分布,导致它们在不同人群中的生物学影响不同。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验